Krystal Biotech Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Krystal Biotech Inc.
Krystal Biotech Inc is an integrated, commercial-stage biotechnology company focused on the discovery, development, manufacturing, and commercialization of genetic medicines to treat diseases with high unmet medical needs. The company uses its patented HSV-1-based gene therapy platform to create vectors that deliver therapeutic transgenes to target cells. It possesses exclusive rights to develop, manufacture, and commercialize VYJUVEK internationally. The company operates as one operating segment focused on pharmaceutical products and manufactures, markets, and sells VYJUVEK in the United States and markets and sells VYJUVEK in the European Union, and Japan.
Frequently asked questions
To buy Krystal Biotech Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Krystal Biotech Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Krystal Biotech Inc. is KRYS:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Krystal Biotech Inc. has its primary listing on NASDAQ (Small cap). You can trade Krystal Biotech Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Krystal Biotech Inc. is available to trade on SaxoInvestor and SaxoTrader. You can buy shares directly and include Krystal Biotech Inc. as part of a broader investment portfolio.
Learn more about investing and trading in Saxo's education hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures—so you can make more informed decisions when considering shares like Krystal Biotech Inc. or others.